Why is Placenta•Cord™ banking so exciting and so promising? Cord blood stem cell transplantation is a proven standard of practice with more than 7000 hematopoietic transplants performed to date. In the future, placental and cord blood stem cells may be able to treat and possibly cure diseases for which there are no adequate therapies today. Research is being conducted to expand future applications of placental and cord blood stem cells to the field of regenerative medicine, which is aimed at repairing damaged or diseased tissues and organs. LifebankUSA™ is working to discover much-needed therapeutic advancements in the placental and cord blood stem cell field through collaborations with some of the premier medical centers around the country. We are working to ensure that the placental and cord blood cells you bank with LifebankUSA today have the potential to deliver the greatest promise for your family tomorrow. The following are some of the potential future regenerative placental and cord blood stem cell applications:
|
The chance that a child will use his/her own stored cord blood stem cells during their lifetime is estimated at 1 in 400 (J.J. Nietfeld and F. Verter). These odds may increase if there is a family history of certain blood disorders or cancers. The potential risks and benefits of stem cell transplantation vary and depend on many factors, such as the amount and quality of the cord blood stem cells collected, the HLA compatibility between recipient and donor, and the client’s overall health.
LifebankUSA™, A Celgene Company. Copyright © 2007